Macrophage-produced IL-10 limits the chemotherapy efficacy in breast cancer.
作者信息
Jiang Xinguo
机构信息
Department of Medicine, VA Palo Alto Health Care System/Stanford University School of Medicine, Stanford, CA 94305, USA.
出版信息
J Zhejiang Univ Sci B. 2015 Jan;16(1):44-5. doi: 10.1631/jzus.B1400352.
Abstract
摘要
相似文献
1
Macrophage-produced IL-10 limits the chemotherapy efficacy in breast cancer.
J Zhejiang Univ Sci B. 2015 Jan;16(1):44-5. doi: 10.1631/jzus.B1400352.
2
CD103+ dendritic cells producing interleukin-12 in anticancer immunosurveillance.
Cancer Cell. 2014 Nov 10;26(5):591-3. doi: 10.1016/j.ccell.2014.10.008.
3
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.
Cancer Cell. 2014 Nov 10;26(5):623-37. doi: 10.1016/j.ccell.2014.09.006. Epub 2014 Oct 16.
4
CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
J Immunol. 2009 Jul 1;183(1):41-50. doi: 10.4049/jimmunol.0803473. Epub 2009 Jun 17.
5
Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma.
Breast Cancer Res Treat. 2004 Nov;88(2):141-8. doi: 10.1007/s10549-004-1426-5.
6
Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer.
Breast Cancer Res Treat. 2010 Jul;122(2):325-36. doi: 10.1007/s10549-009-0570-3. Epub 2009 Oct 3.
7
Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
PLoS One. 2014 Nov 19;9(11):e113597. doi: 10.1371/journal.pone.0113597. eCollection 2014.
8
Roles for CD8 T Cells and IL-10 in the Resolution of Paclitaxel-Induced Neuropathic Pain.
J Neurosci. 2017 Mar 15;37(11):2803-2805. doi: 10.1523/JNEUROSCI.3917-16.2017.
9
A dendritic cell population generated by a fusion of GM-CSF and IL-21 induces tumor-antigen-specific immunity.
J Immunol. 2010 Dec 15;185(12):7358-66. doi: 10.4049/jimmunol.1002201. Epub 2010 Nov 12.
10
Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice.
J Immunotoxicol. 2012 Jul-Sep;9(3):275-81. doi: 10.3109/1547691X.2012.655343. Epub 2012 Mar 27.
引用本文的文献
1
Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies.
J Immunother Precis Oncol. 2024 May 2;7(2):73-81. doi: 10.36401/JIPO-23-16. eCollection 2024 May.
2
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
Int J Mol Sci. 2023 Feb 16;24(4):4002. doi: 10.3390/ijms24044002.
3
study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer.
Iran J Basic Med Sci. 2022 Dec;25(12):1442-1451. doi: 10.22038/IJBMS.2022.66065.14524.
4
Interleukin-10: A double-edged sword in breast cancer.
Tzu Chi Med J. 2021 Feb 24;33(3):203-211. doi: 10.4103/tcmj.tcmj_162_20. eCollection 2021 Jul-Sep.
5
A Survey on the Role of Interleukin-10 in Breast Cancer: A Narrative.
Rep Biochem Mol Biol. 2018 Oct;7(1):30-37.
6
Exploring immuno-regulatory mechanisms in the tumor microenvironment: Model and design of protocols for cancer remission.
PLoS One. 2018 Sep 5;13(9):e0203030. doi: 10.1371/journal.pone.0203030. eCollection 2018.
7
Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow.
J Zhejiang Univ Sci B. 2017;18(12):1055-1063. doi: 10.1631/jzus.B1700003.
8
Successful treatment of accessory breast cancer with endocrine therapy.
J Zhejiang Univ Sci B. 2017;18(1):70-75. doi: 10.1631/jzus.B1600220.
9
Correlation analysis of gene polymorphisms and β-lactam allergy.
J Zhejiang Univ Sci B. 2015 Jul;16(7):632-9. doi: 10.1631/jzus.B1400309.
本文引用的文献
1
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.
Cancer Cell. 2014 Nov 10;26(5):623-37. doi: 10.1016/j.ccell.2014.09.006. Epub 2014 Oct 16.
2
Tumor-associated macrophages: from mechanisms to therapy.
Immunity. 2014 Jul 17;41(1):49-61. doi: 10.1016/j.immuni.2014.06.010.
3
Harnessing the immune system for the treatment of breast cancer.
J Zhejiang Univ Sci B. 2014 Jan;15(1):1-15. doi: 10.1631/jzus.B1300264.
4
Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.
J Clin Invest. 2013 Nov;123(11):4859-74. doi: 10.1172/JCI65180.
5
Macrophage regulation of tumor responses to anticancer therapies.
Cancer Cell. 2013 Mar 18;23(3):277-86. doi: 10.1016/j.ccr.2013.02.013.
6
Role of macrophage targeting in the antitumor activity of trabectedin.
Cancer Cell. 2013 Feb 11;23(2):249-62. doi: 10.1016/j.ccr.2013.01.008.
7
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
Cancer Discov. 2011 Jun;1(1):54-67. doi: 10.1158/2159-8274.CD-10-0028. Epub 2011 Jun 1.
8
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.
Cancer Cell. 2011 Jan 18;19(1):31-44. doi: 10.1016/j.ccr.2010.11.009. Epub 2011 Jan 6.
9
Interleukin-12 and the regulation of innate resistance and adaptive immunity.
Nat Rev Immunol. 2003 Feb;3(2):133-46. doi: 10.1038/nri1001.
Zotero 插件